IT1259140B - Formulazioni farmaceutiche per la somministraziane orale di calcitonina - Google Patents
Formulazioni farmaceutiche per la somministraziane orale di calcitoninaInfo
- Publication number
- IT1259140B IT1259140B ITPD920141A ITPD920141A IT1259140B IT 1259140 B IT1259140 B IT 1259140B IT PD920141 A ITPD920141 A IT PD920141A IT PD920141 A ITPD920141 A IT PD920141A IT 1259140 B IT1259140 B IT 1259140B
- Authority
- IT
- Italy
- Prior art keywords
- calcitonin
- oral administration
- pharmaceutical formulations
- formulations
- lysogangliosides
- Prior art date
Links
- 102000055006 Calcitonin Human genes 0.000 title abstract 3
- 108060001064 Calcitonin Proteins 0.000 title abstract 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title abstract 3
- 229960004015 calcitonin Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
La presente invenzione si riferisce a composizioni farmaceutiche costituite principalmente da un polipeptide, ad esempio calcitonina, e lisogangliosidi co-liofilizzati, per la somministrazione orale in forma di capsule e/o compresse gastroprotette, tali da promuovere l'assorbimento e la biodisponibilità della calcitonina senza creare scompensi biologici agli organi e tessuti che entrano in contatto con i composti impiegati nelle formulazioni.-
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITPD920141A IT1259140B (it) | 1992-07-30 | 1992-07-30 | Formulazioni farmaceutiche per la somministraziane orale di calcitonina |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITPD920141A IT1259140B (it) | 1992-07-30 | 1992-07-30 | Formulazioni farmaceutiche per la somministraziane orale di calcitonina |
Publications (3)
Publication Number | Publication Date |
---|---|
ITPD920141A0 ITPD920141A0 (it) | 1992-07-30 |
ITPD920141A1 ITPD920141A1 (it) | 1994-01-30 |
IT1259140B true IT1259140B (it) | 1996-03-11 |
Family
ID=11390033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITPD920141A IT1259140B (it) | 1992-07-30 | 1992-07-30 | Formulazioni farmaceutiche per la somministraziane orale di calcitonina |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1259140B (it) |
-
1992
- 1992-07-30 IT ITPD920141A patent/IT1259140B/it active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ITPD920141A0 (it) | 1992-07-30 |
ITPD920141A1 (it) | 1994-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ228130A (en) | Therapeutic composition comprising fenofibrate and a solid surfactant which has been co-micronised; preparatory process | |
EP0552256A4 (it) | ||
UA32512C2 (uk) | Похідні ксантину, спосіб їх одержання, та фармацевтична композиція | |
GR3004448T3 (it) | ||
ZA888734B (en) | Stabilized medicinal substances,a process for the preparation thereof,and stable medicinal formulations | |
ATE99941T1 (de) | Medikamente enthaltend salmeterol und fluticason. | |
GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
HUT59306A (en) | Process for producing pharmaceutical compositions comprising l-carnitine | |
ATE224717T1 (de) | Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin | |
ZA905861B (en) | Pharmaceutical composition for oral administration containing nac | |
CA2038744A1 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
DE59811768D1 (de) | Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine | |
DE69004532D1 (de) | Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen. | |
GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
FR2651435B1 (it) | ||
EP0230264A3 (en) | Pharmaceutical composition for nasal application, process for its preparation and its use | |
IL85963A0 (en) | Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances | |
AU536582B2 (en) | Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends | |
IT1259140B (it) | Formulazioni farmaceutiche per la somministraziane orale di calcitonina | |
GR3018365T3 (en) | Use of 15-deoxyspergualine as a medicament. | |
HK135494A (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
UA32583C2 (uk) | Похідні арилтіоалкілтіопіридину | |
IE883402L (en) | Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance | |
HUP0100634A2 (hu) | Pentaeritrit-tetranitrátot tartalmazó gyógyászati készítmények | |
FR2592793A1 (fr) | Association de sulpiride et de diazepam a titre de composition pharmaceutique, notamment utile dans le traitement des manifestations fonctionnelles digestives liees au stress, et son utilisation pour la preparation de ladite composition. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19960701 |